De Novo DNA

Curated by Signal

Provider of software tool for genetic system

Overview

De Novo DNA has designed a software for the genetic system of prokaryotes. The software aids in designing DNA sequence for better protein expression, controlled translation rate, for applications in next-generation biofuels, renewable materials, recombinant enzymes, and medical therapeutics.

Key facts

Founded: 2012
Headquarters: State College, United States
Stage: Sign up to view
Industry: Health Technology

Business model

3 products and services: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

Heartify
Provider of a heart health monitoring app
Health TechnologyBoston, United States
PhysIQ
Provider of AI-based personalized physiology data analytics platform.
Health TechnologyNaperville, United States
Pilates Wheel
Online platform offering video based Pilates training
Health TechnologyLos Angeles, United States

About De Novo DNA

What does De Novo DNA do?

De Novo DNA has designed a software for the genetic system of prokaryotes.

Where is De Novo DNA headquartered?

De Novo DNA is headquartered in State College, United States.

When was De Novo DNA founded?

De Novo DNA was founded in 2012.

Which sector is De Novo DNA in?

De Novo DNA operates in Health Technology.

Who are De Novo DNA's competitors?

Companies similar to De Novo DNA include Heartify, PhysIQ, and Pilates Wheel.